Bacterial resistance to antibiotics can occur with which situations? (Select all that apply)

Choice A reason: Oral decongestants like pseudoephedrine are not inherently more potent than nasal sprays like oxymetazoline. Both stimulate alpha-adrenergic receptors to constrict nasal blood vessels, but nasal sprays often provide more rapid, localized relief. Potency depends on dose and delivery, not route, making this incorrect.

Choice B reason: Oral decongestants do not have an immediate onset. They require absorption through the gastrointestinal tract, with effects starting in 30-60 minutes. Nasal sprays act within minutes due to direct mucosal application, making them faster for acute sinus symptom relief, unlike slower-acting oral forms.

Choice C reason: Oral decongestants typically have a longer duration of action (4-6 hours for pseudoephedrine) compared to nasal sprays (often shorter unless long-acting). Shorter duration is not a benefit, as prolonged relief is preferred for sinus congestion, making this an incorrect advantage of oral administration.

Choice D reason: Oral decongestants avoid rebound congestion, a common issue with nasal sprays like oxymetazoline, which can cause rhinitis medicamentosa with prolonged use. Oral agents like pseudoephedrine act systemically, reducing nasal congestion without local dependence, making them safer for extended use without worsening symptoms upon discontinuation.

Choice A reason: Protamine sulfate is the antidote for heparin overdose, neutralizing heparin’s anticoagulant effect by binding to it, forming an inactive complex. This reverses excessive anticoagulation, reducing bleeding risk in patients with prolonged aPTT (e.g., 90 seconds), making it the appropriate treatment for heparin-induced bleeding.

Choice B reason: Vitamin E has no role in reversing heparin-induced bleeding. It is an antioxidant with potential antiplatelet effects, which could worsen bleeding. Heparin’s action, enhancing antithrombin to inhibit thrombin and factor Xa, is specifically countered by protamine sulfate, not vitamin E.

Choice C reason: Vitamin K reverses warfarin, not heparin, by restoring vitamin K-dependent clotting factors. Heparin acts via antithrombin, independent of vitamin K, and its overdose causes bleeding correctable by protamine sulfate. Vitamin K is ineffective for heparin-related bleeding, making this incorrect.

Choice D reason: Potassium chloride treats hypokalemia, not heparin-induced bleeding. Heparin’s anticoagulant effect, prolonging aPTT, is unrelated to potassium levels. Administering potassium chloride would not address excessive anticoagulation or bleeding, making it irrelevant for managing heparin overdose complications.